Systemic Bio News Today

3D Systems Corporation (NYSE:DDD) Q4 2023 Earnings Call Transcript February 28, 2024 3D Systems Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the 3D Systems Fourth Quarter and Full-Year 2023 Earnings Call and Webcast. [Operator […]

DDD earnings call for the period ending December 31, 2023.

DDD earnings call for the period ending December 31, 2023.

3D Systems announced two additions to its executive leadership team. Effective December 13, 2023, Jeffrey Creech has joined the company as Executive Vice President and Chief Financial Officer. Mr....

Jeffrey Creech joins as Chief Financial OfficerHarriss T. Currie joins as President - Regenerative MedicineNew organization structure reflects technical progress and potential for significant value creation through new regenerative medicine

Jeffrey Creech joins as Chief Financial OfficerHarriss T. Currie joins as President - Regenerative MedicineNew organization structure reflects technical progress and potential for significant value...

Human life-like in vitro model of radiation damage sustained to the lung opens an unprecedented window into the early disease process, and opportunities for drug development 

The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.

<p>Researchers have developed a human <em>in vitro</em> model that closely mimics the complexities of radiation-induced lung injury (RILI) and radiation dose sensitivity of the human lung. Using a previously developed microfluidic human Lung Alveolus Chip lined by human lung alveolar epithelial cells interfaced with lung capillary cells to recreate the alveolar-capillary interface <em>in vitro</em>, the researchers recapitulated many of th...

DDD earnings call for the period ending June 30, 2023.